Literature DB >> 12204866

A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma.

Nobuyuki Hizawa1, Etsuro Yamaguchi, Satoshi Konno, Yoko Tanino, Eisei Jinushi, Masaharu Nishimura.   

Abstract

The CC chemokine regulated upon activation, normal T-cell expressed and secreted (RANTES) attracts eosinophils, basophils, and T cells during inflammation and immune response, indicating a possible role for this chemokine in asthma. Both the -403A and -28G alleles of the RANTES promoter region exhibit significantly enhanced promoter activity in reporter constructs in vitro. We therefore investigated the genetic influence of these alleles on the development of asthma using case-control analysis in a Japanese population (298 patients with asthma and 311 control subjects). Given the evidence for heterogeneity of asthma according to age at onset, we divided patients with asthma into three subgroups: 117 late-onset patients with asthma (onset at more than 40 years of age), 83 middle-onset patients with asthma (onset at 20 to 40 years of age), and 98 early-onset patients with asthma (onset at less than 20 years of age). The -28G allele was significantly associated with late-onset asthma (odds ratio = 2.033; 95% confidence interval, 1.379-2.998; corrected p < 0.0025) but was not associated with the other two asthma subgroups. The -403A allele was not associated with any of the asthma subgroups. Further evidence of the importance of the -28G allele was a significant increase in the production of RANTES in vitro in individuals who carried this allele. Our findings suggest that, among Japanese, the -28G allele of the RANTES promoter region confers susceptibility to late-onset asthma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204866     DOI: 10.1164/rccm.200202-090OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  29 in total

1.  Exploring the origins of asthma: Lessons from twin studies.

Authors:  Simon Francis Thomsen
Journal:  Eur Clin Respir J       Date:  2014-09-01

2.  Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis.

Authors:  Rachel Nadif; Margaret Mintz; Selma Rivas-Fuentes; Anne Jedlicka; Elise Lavergne; Mathieu Rodero; Francine Kauffmann; Christophe Combadière; Steven R Kleeberger
Journal:  Cytokine       Date:  2006-02-07       Impact factor: 3.861

Review 3.  The adult asthmatic.

Authors:  Amir A Zeki; Nicholas J Kenyon; Ken Yoneda; Samuel Louie
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

4.  The traditional Chinese herbal formula ASHMI inhibits allergic lung inflammation in antigen-sensitized and antigen-challenged aged mice.

Authors:  Paula J Busse; Brian Schofield; Neil Birmingham; Nan Yang; Ming-Chuan Wen; Tengfei Zhang; Kamal Srivastava; Xiu-Min Li
Journal:  Ann Allergy Asthma Immunol       Date:  2010-03       Impact factor: 6.347

5.  RANTES gene promoter polymorphisms are associated with bronchial hyperresponsiveness in Korean children with asthma.

Authors:  Myung Hyun Sohn; Seung-Hyun Kim; Kyung-Won Kim; Hye Mi Jee; Hae-Sim Park; Kyu-Earn Kim
Journal:  Lung       Date:  2007-11-08       Impact factor: 2.584

6.  Effect of RANTES promoter genotype on the severity of intestinal metaplasia in Helicobacter pylori-infected Japanese subjects.

Authors:  Tomomitsu Tahara; Tomiyasu Arisawa; Tomoyuki Shibata; Masakatsu Nakamura; Hiromi Yamashita; Daisuke Yoshioka; Masaaki Okubo; Naoko Maruyama; Toshiaki Kamano; Yoshio Kamiya; Hiroshi Fujita; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Hiroshi Nakano; Ichiro Hirata
Journal:  Dig Dis Sci       Date:  2008-10-29       Impact factor: 3.199

7.  Association between regulated upon activation, normal T cells expressed and secreted (RANTES) -28C/G polymorphism and asthma risk--a meta-analysis.

Authors:  Qiaoqiao Fang; Furu Wang; Deyu Zhao
Journal:  Int J Med Sci       Date:  2010-02-10       Impact factor: 3.738

Review 8.  CCL5 as a potential immunotherapeutic target in triple-negative breast cancer.

Authors:  Dandan Lv; Yan Zhang; Ha-Jeong Kim; Lixing Zhang; Xiaojing Ma
Journal:  Cell Mol Immunol       Date:  2013-02-04       Impact factor: 11.530

Review 9.  Complexities of diagnosis and treatment of allergic respiratory disease in the elderly.

Authors:  Paula J Busse; Kiran Kilaru
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

10.  The Role of RANTES Promoter Polymorphism in Functional Dyspepsia.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Hiromi Yamashita; Ichiro Hirata; Tomiyasu Arisawa
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.